logo

For the Inventor, By the Inventor

Chiba, Japan

Tadayuki Kuraishi

This inventor holds 21 USPTO granted patents, plus 2 CIPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Ss Pharmaceutical Co., Ltd.. Active years: 1983-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tadayuki Kuraishi. Retrieved from https://idiyas.com/inventor/tadayuki-kuraishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.8

ph-index = 7

Forward Citations = 144(Granted Patents)


Location History:

  • Chiba, JP (1983 - 1996)
  • Narashino, JP (1995 - 1998)

Company Filing History:

goldMedal21 out of 90 
 
Ss Pharmaceutical Co., Ltd.
 patents

Years Active: 1983-1998

Loading Chart...
Loading Chart...
Areas of Expertise:
Quinoline Derivatives
Platinum Complex
Antibacterial Agent
Anti-inflammatory
Piperazine Compounds
Thiazinobenzimidazole
Carboxylic Acids
Arylamide Derivatives
Dexamethasone
Triazole Derivatives
Malignant Tumor Treatment
Hyperlipemia Treatment
21 patents (USPTO):Explore Patents
1. 5789419 - 4-quinolinone derivative or salt thereof (1998-08-04),
2. 5585511 - Platinum complex and malignant tumor treating drug containing the same (1996-12-17),
3. 5532371 - Piperazine substituted carboxylic acid derivatives for treating (1996-07-02),
4. 5498780 - Platinum complex and malignant tumor treating drug containing the same (1996-03-12),
5. 5440036 - 1,4-benzoxazine derivatives (1995-08-08),
6. 5430028 - 5-aminoquinolone carboxylic acid derivative and antibacterial agent (1995-07-04),
7. 5411972 - Arylamide derivatives for treating hyperlipemia (1995-05-02),
8. 5385900 - Quinoline carboxylic acid derivatives (1995-01-31),
9. 5324735 - Quinoline carboxylic acid derivatives (1994-06-28),
10. 5300517 - Piperidine compounds having anti-acetylcholinesterase activity (1994-04-05),
11. 5240934 - Quinoline derivatives (1993-08-31),
12. 5231101 - Benzo[5,6]cyclohepta[1,2-B]pyridine derivatives and antiallergic agents (1993-07-27),
13. 5190951 - Quinoline derivatives (1993-03-02),
14. 5159091 - Process for preparing 21-desoxyprednisolone 17-esters (1992-10-27),
15. 5147886 - Triazole derivatives and a composition for treating mycoses (1992-09-15),

Title: Tadayuki Kuraishi: Innovator in Oncological Treatments

Introduction

Tadayuki Kuraishi, an accomplished inventor based in Chiba, Japan, has made significant contributions to the field of pharmaceutical development, particularly in cancer treatments. With a remarkable portfolio of 21 patents, his work demonstrates a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Among his latest innovations is a patent for a 4-quinolinone derivative or salt thereof, specifically a platinum complex that serves as a malignant tumor treating drug. This complex is notable for its excellent antitumor effects and safety profile, alongside its high solubility in water. Such properties make it highly valuable for treating various malignant tumors, offering hope to patients and healthcare providers alike.

Career Highlights

Tadayuki Kuraishi is currently affiliated with Ss Pharmaceutical Co., Ltd., a company that reflects his dedication to pharmaceutical innovation. His work in this esteemed organization has enabled him to push the boundaries of cancer treatment, leading to significant advancements in the development of effective therapeutic agents.

Collaborations

Throughout his career, Kuraishi has collaborated with esteemed colleagues such as Susumu Sato and Naokata Taido. These partnerships have fostered a collaborative environment that encourages the sharing of ideas and resources, ultimately enriching the research and development process.

Conclusion

Tadayuki Kuraishi's contributions to oncology through his innovative patents underscore the importance of research and development in the pharmaceutical industry. His latest advancements not only highlight his expertise but also pave the way for improved treatment options for patients battling malignant tumors, illustrating the critical role of inventors in shaping the future of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…